Analytical Data
-
基因名
HOXA2
- Application
-
别名
Homeobox protein Hox-1K (HOX1K)
-
种属
Human
-
表达系统
Yeast
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O43364
-
表达区间
26-124aa
-
分子量
12.0
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HOXA2 is a member of the Homeobox (HOX) gene family, which plays a crucial role in the regulation of developmental processes, particularly in the formation of the anterior-posterior axis during embryogenesis. Research has shown that HOXA2 is essential for normal craniofacial development, and its dysfunction is associated with various congenital disorders, including syndromic and non-syndromic hearing loss. Studies involving HOXA2 recombinant protein aim to elucidate its functional mechanisms, cellular interactions, and potential therapeutic applications. These investigations often involve the cloning and expression of HOXA2 in various systems, allowing researchers to analyze the protein's role in gene regulation and its impact on downstream signaling pathways. Understanding the precise function of HOXA2 through recombinant protein techniques can lead to advancements in gene therapy strategies and facilitate the development of interventions for conditions related to HOXA2 disruption. This research has significant implications not only for developmental biology but also for understanding the genetic underpinnings of craniofacial disorders and designing targeted therapies.
